Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
An inherited metabolic disease that is has its basis in the disruption of sphingolipid biosynthetic process.
Biomarker and diagnostic research for disorder of sphingolipid biosynthesis has been reported in the published literature.
No clinical trials have been registered for disorder of sphingolipid biosynthesis.
269 publications have been identified in PubMed for disorder of sphingolipid biosynthesis. Research spans Basic Science / Preclinical (61%), Review / Meta-Analysis (20%), and Gene Therapy / Novel Therapeutics (7%).
Research Type | Count | % of Total |
|---|---|---|
Laboratory research | 165 | 61% |
Data assembled from 2 of 12 sources · Last updated Sep 18, 2026, 11:50 PM UTC
Research summaries
54 |
20% |
New treatment approaches | 19 | 7% |
Testing and diagnosis research | 15 | 6% |
Disease patterns and progression | 12 | 4% |
Clinical study results | 4 | 1% |
Nicholson RJ (2026). [PMID: 41232539](https://pubmed.ncbi.nlm.nih.gov/41232539/). *Cell metabolism*. [Gene Therapy / Novel Therapeutics]
Chen ZC (2026). [PMID: 41474773](https://pubmed.ncbi.nlm.nih.gov/41474773/). *Brain Behav*. [Basic Science / Preclinical]
Simonetta I (2026). [PMID: 41827876](https://pubmed.ncbi.nlm.nih.gov/41827876/). *Cells*. [Review / Meta-Analysis]
Sun L (2026). [PMID: 41268620](https://pubmed.ncbi.nlm.nih.gov/41268620/). *Cell Biol Int*. [Review / Meta-Analysis]
Morigny P (2026). [PMID: 42138073](https://pubmed.ncbi.nlm.nih.gov/42138073/). *J Clin Invest*. [Gene Therapy / Novel Therapeutics]
Albers M (2026). [PMID: 41917001](https://pubmed.ncbi.nlm.nih.gov/41917001/). *Nat Commun*. [Basic Science / Preclinical]
Su S (2026). [PMID: 41530645](https://pubmed.ncbi.nlm.nih.gov/41530645/). *Sci China Life Sci*. [Review / Meta-Analysis]
He Y (2026). [PMID: 41933666](https://pubmed.ncbi.nlm.nih.gov/41933666/). *Neurobiol Dis*. [Gene Therapy / Novel Therapeutics]
He S (2026). [PMID: 41513633](https://pubmed.ncbi.nlm.nih.gov/41513633/). *Nat Commun*. [Epidemiology / Natural History]
Pilotto F (2026). [PMID: 41489058](https://pubmed.ncbi.nlm.nih.gov/41489058/). *Adv Sci (Weinh)*. [Basic Science / Preclinical]